Pharmaceutical Intermediates Since 2006
Sritha ChemsPvt Ltd
Delivering high-quality pharmaceutical intermediates with uncompromising standards in synthesis, safety, and compliance.
About Us
Excellence in Pharmaceutical Synthesis
Established in 2006 in Hyderabad, India, Sritha Chems is a specialist manufacturer of pharmaceutical intermediates. From our initial 9-reactor facility with 23.3 KL capacity, we have grown into a modern GMP-compliant operation with advanced analytical capabilities and expanded production capacity.
We serve leading API producers across India and globally, delivering intermediates for critical therapeutic areas including oncology, cardiovascular, and urology.
View Our JourneyOur Products
Pharmaceutical Intermediates
We manufacture a growing catalog of high-quality intermediates for leading API producers worldwide. Our product range continues to expand as we develop new synthesis capabilities.
| # | Intermediate | CAS No. | Intermediate For |
|---|---|---|---|
| 1 | 3-Acetyl Pyridine | 350-03-81 | Imitanib Mesylate / Residonate |
| 2 | 3-Pyridyl Acetic Acid Hydrochloride | 6419-36-9 | Residonic Acid / Sodium |
| 3 | 2-Amino-6-{4-Fluro phenyl}-methyl}-amino}-3-Pyridinyl-carbamic acid ethyl ester, Hydrochloride | 33400-45-2 | Flupirtine |
| 4 | 3-[(3-Amino-4-Methyl amino benzoyl) pyridine-2-yl-amino] Propionic acid Ethyl Ester | 212322-56-0 | Dabigatran |
| 5 | N-(4-Cyanophenyl) amino acetic acid | 42288-26-6 | Dabigatran |
| 6 | Methyl Benzothiazine Isopropyl Ester | 118854-48-1 | Meloxicam |
| 7 | N-(2-Methyl-5-amino phenyl)-5-pyridin-3-yl-pyrimidine-2Amine | 152460-10-1 | Imitanib Mesylate |
| 8 | 4-(4-Methyl piperazine-1 yl methyl-N-4-methyl 3-4pyridin-3yl pyrimidine-2 yl amino phenyl Benzamide | 152459-95-5 | Imitanib Mesylate |
| 9 | 1(2-Methyl-5-Nitro-Phenyl) Guandirine Nitrate | 152460-08-7 | Imitanib Mesylate |
| 10 | R-(-)-5-(2-Amino-propyl)-2-methoxy-benzene sulfonamide | 112101-81-2 | Tamsulosin |
| 11 | 4-Methoxy-3-Sulfamoyl Phenyl Acetone | 116091-63-5 | Tamsulosin |
| 12 | 2(2-Ethoxy Phenoxy) Ethyl Bromide | 08-03-3259 | Tamsulosin |
Showing 12 of 12 intermediates. Catalog expanding — contact us for custom synthesis inquiries.
Infrastructure
World-Class Facilities
Multi-purpose production block with stainless steel and glass-lined reactors. Starting capacity of 23.3 KL, now expanded to over 70 KL with modern GMP-compliant facilities across 9,000 sq metres.
Multi-purpose production block with stainless steel and glass-lined reactors. Starting capacity of 23.3 KL, now expanded to over 70 KL with modern GMP-compliant facilities across 9,000 sq metres.
Capabilities
Advanced Synthesis Technologies
Hydrogenation
Max pressure: 20 KG. Stainless steel and glass-lined reactors from 2,000 to 5,000 liters.
Chiral Synthesis
Chiral resolution (2,000 L, >100 Kg/batch), enzymatic resolution (6,000 L, >200 Kg/batch), and asymmetric hydrogenation.
Oxidation Chemistry
H₂O₂ and KMnO₄ based oxidation systems for diverse intermediate synthesis.
High Vacuum
Advanced distillation and solvent recovery systems operating under high vacuum conditions.
Quality System
Comprehensive QMS covering documentation, calibration, change control, stability, and release management.
Process Validation
Full validation management with deviation, OOS, CAPA, and employee training programs.
Our Journey
Milestones of Growth
Founded
- Established with 9 reactors
- 23.3 KL capacity
- 2,000 sq m production block
- 12 employees
Commercial Launch
- Commercial production begins
- First client partnerships
- External analytical lab support
Major Expansion
- New QC block with HPLC & GC (Aug)
- 9,000 sq m GMP production block (Oct)
- Capacity tripled
- 30 employees
Continued Growth
- MEE Plant for effluent management
- New solvent recovery plant
- Warehouse construction
- Power upgraded to 650 KVA
- Method validations
Founded
- Established with 9 reactors
- 23.3 KL capacity
- 2,000 sq m production block
- 12 employees
Commercial Launch
- Commercial production begins
- First client partnerships
- External analytical lab support
Major Expansion
- New QC block with HPLC & GC (Aug)
- 9,000 sq m GMP production block (Oct)
- Capacity tripled
- 30 employees
Continued Growth
- MEE Plant for effluent management
- New solvent recovery plant
- Warehouse construction
- Power upgraded to 650 KVA
- Method validations
Quality Assurance
Committed to Compliance
Our comprehensive quality management system ensures every product meets the highest pharmaceutical standards, from incoming raw materials through to final dispatch.
- Documentation Management
- Calibration Management
- Change Control Management
- Process Validation
- Stability Study Management
- Release Management
- Internal Audit Management
- Deviation / OOS / CAPA Management
- Employee Training Management
See Us in Action
Our Facilities
Contact Us
Let's Work Together
Whether you need a custom intermediate or want to explore our product catalog, our team is ready to assist.
Contact Information
Reach out to us directly through any of the channels below.